(Q43897966)

English

Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil

scientific article published in December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

0 references

diethylcarbamazine

1 reference

based on heuristic

inferred from title

5

object named as

Cynthia Braga

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Ana Wládia Lima

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Zulma Medeiros

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Zailde Carvalho Dos Santos

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Gertrudes Monteiro da Costa

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Revista da Sociedade Brasileira de Medicina Tropical

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

745-750

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008.

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Treatment costs and work time loss due to episodic adenolymphangitis in lymphatic filariasis patients in rural communities of Orissa, India

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Screening of army soldiers for Wuchereria bancrofti infection in the metropolitan Recife region, Brazil: implications for epidemiological surveillance

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

The epidemiological delimitation of lymphatic filariasis in an endemic area of Brazil, 41 years after the first recorded case

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Bancroftian filariasis in two urban areas of Recife, Brazil: pre-control observations on infection and disease

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Mass treatment to eliminate filariasis in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822012000600017

21 January 2018

Identifiers

10.1590/S0037-86822012000600017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43897966&oldid=2104233823"